We are live on ! Find out more
SMMT icon

Summit Therapeutics
SMMT

14 hedge funds and large institutions have $30.5M invested in Summit Therapeutics in 2017 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.01% less ownership

Funds ownership: 4.35% → 4.35% (-0.01%)

7% less funds holding

Funds holding: 15 → 14 (-1)

15% less capital invested

Capital invested by funds: $35.8M → $30.5M (-$5.32M)

25% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 4

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

Holders
14
Holders Change
-1
Holders Change %
-6.67%
% of All Funds
0.35%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
2
Increased
3
Reduced
4
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$207K
2
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$28.1K
3
Deutsche Bank
Deutsche Bank
Germany
+$22.1K
4
TRCT
Tower Research Capital (TRC)
New York
+$3.38K
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$11

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$89K
2
Axa
Axa
France
-$82.3K
3
SFM
Sphera Funds Management
Israel
-$61.2K
4
Millennium Management
Millennium Management
New York
-$59.3K
5
Wells Fargo
Wells Fargo
California
-$16K
Name Holding Trade Value Shares
Change 		Change in
Stake
LPU
1
Lansdowne Partners (UK)
United Kingdom
$10.6M – – –
Point72 Asset Management
2
Point72 Asset Management
Connecticut
$9.13M – – –
Axa
3
Axa
France
$3.27M -$82.3K -7,309 -2%
First Eagle Investment Management
4
First Eagle Investment Management
New York
$1.92M – – –
SFM
5
Sphera Funds Management
Israel
$1.56M -$61.2K -5,432 -4%
GPCM
6
Granite Point Capital Management
Massachusetts
$1.33M – – –
KCM
7
Knoll Capital Management
Florida
$1.1M – – –
Millennium Management
8
Millennium Management
New York
$864K -$59.3K -5,270 -6%
Renaissance Technologies
9
Renaissance Technologies
New York
$439K +$207K +18,398 +92%
Acadian Asset Management
10
Acadian Asset Management
Massachusetts
$145K +$11 +1 +0%
Deutsche Bank
11
Deutsche Bank
Germany
$81K +$22.1K +1,964 +38%
Royal Bank of Canada
12
Royal Bank of Canada
Ontario, Canada
$28K +$28.1K +2,500 New
State of Tennessee, Department of Treasury
13
State of Tennessee, Department of Treasury
Tennessee
$17K -$8.25K -733 -33%
TRCT
14
Tower Research Capital (TRC)
New York
$3K +$3.38K +300 New
Morgan Stanley
15
Morgan Stanley
New York
– -$89K -6,721 Closed
Wells Fargo
16
Wells Fargo
California
– -$16K -1,200 Closed
UBS Group
17
UBS Group
Switzerland
– -$9K -702 Closed

SMMT Hedge Fund Activity: Q2 2017 in Review

14 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Summit Therapeutics (SMMT) for Q2 2017, worth a combined $30.5M — down 15% from $35.8M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of SMMT and 2 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 3 added.

The largest buyer was Renaissance Technologies, adding an estimated $207K. The largest seller was Morgan Stanley, exiting entirely with an estimated $89K sold.

  • 14 institutional investors held Summit Therapeutics (SMMT) as of Q2 2017, down from 15 in Q1 2017.
  • Funds reported $30.5M of Summit Therapeutics stock for Q2 2017, down 15% quarter-over-quarter.
  • 2 funds opened new Summit Therapeutics positions in Q2 2017 and 3 closed out, a net change of -1 holder.
  • The largest Summit Therapeutics buyer in Q2 2017 was Renaissance Technologies, an estimated $207K added.
  • The largest Summit Therapeutics seller in Q2 2017 was Morgan Stanley, an estimated $89K sold.

Based on aggregated 13F filings for Q2 2017.